Lipophilic salts of poorly soluble compounds to enable high-dose lipidic SEDDS formulations in drug discovery
2017
Abstract Self-emulsifying drug delivery systems (SEDDS) have been used to solubilize poorly water-soluble drugs to improve exposure in high-dose pharmacokinetic (PK) and
toxicokinetic(TK) studies. However, the absorbable dose is often limited by drug solubility in the lipidic SEDDS vehicle. This study focuses on increasing solubility and drug loading of ionizable drugs in SEDDS vehicles using
lipophiliccounterions to prepare
lipophilicsalts of drugs. SEDDS formulations of two
lipophilicsalts—
atazanavir-2-naphthalene sulfonic acid (ATV-2-NSA) and
atazanavir-dioctyl sulfosuccinic acid (ATV-Doc)—were characterized and their performance compared to
atazanavir(ATV)
free baseformulated as an aqueous crystalline suspension, an organic solution, and a SEDDS suspension, using in vitro , in vivo , and in silico methods. ATV-2-NSA exhibited ∼6-fold increased solubility in a SEDDS vehicle, allowing emulsion dosing at 12 mg/mL. In rat PK studies at 60 mg/kg, the ATV-2-NSA SEDDS emulsion had comparable exposure to the
free-basesolution, but with less variability, and had better exposure at high dose than aqueous suspensions of ATV
free base. Trends in dose-dependent exposure for various formulations were consistent with GastroPlus™ modeling. Results suggest use of
lipophilicsalts is a valuable approach for delivering poorly soluble compounds at high doses in Discovery.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
45
References
28
Citations
NaN
KQI